Fierce Healthcare April 18, 2024
Noah Tong

Lawmakers pressed Department of Health and Human Services Secretary Xavier Becerra over the Biden administration’s stance toward Medicare Advantage, rural health and more during budgetary hearings this week.

Some lawmakers praised the administration’s commitment to key priorities like the Medicare drug price negotiations program. At times, members on both sides of the aisle grew exasperated at Becerra’s unwillingness to directly answer questions.

But an exchange with Rep. Buddy Carter, R-Ga., over copay accumulators more than 90 minutes into Becerra’s third day of testimony drew some of the toughest criticism yet from patient advocacy groups, leaving some to question where his loyalties lie and others wondering if he’s simply uninformed on the issue.

‘I think that the Secretary’s testimony was an...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, HHS, Insurance, Medicare Advantage, Patient / Consumer
More than half of US adults could benefit from GLP-1 medications, researchers find
Data show 24.3% of U.S. adults had chronic pain in past three months in 2023
GLP-1 drug coverage for obesity making inroads with large employers: Mercer
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Advocate Health takes to Capitol Hill on hospital at home: 5 notes

Share This Article